APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Pet Genetic Defect Screening Platform

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pet Genetic Defect Screening Platform Market Outlook and Growth Opportunities 2026

Report ID 174213240415 April 2026Not stated

Choose your research edition.

Industry ResearchPet Genetic Defect Screening Platform Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Pet Genetic Defect Screening Platform Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Pet Genetic Defect Screening Platform Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pet Genetic Defect Screening Platform Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pet Genetic Defect Screening Platform Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Pet Genetic Defect Screening Platform market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pet Genetic Defect Screening Platform is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pet Genetic Defect Screening Platform market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pet Genetic Defect Screening Platform market include Wisdom Panel, Embark Veterinary, Basepaws, Orivet Genetic Pet Care, Paw Print Genetics, Animal Genetics, VetGen, Antagene and Laboklin, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pet Genetic Defect Screening Platform market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pet Genetic Defect Screening Platform and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pet Genetic Defect Screening Platform revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pet Genetic Defect Screening Platform market.

Pet Genetic Defect Screening Platform Segment by Company

Wisdom Panel

Embark Veterinary

Basepaws

Orivet Genetic Pet Care

Paw Print Genetics

Animal Genetics

VetGen

Antagene

Laboklin

UC Davis

OptiGen

VHLGenetics

Sinogene

PawKnows

Circle Dog

BGI Genomics

GENEWIZ

Pet Genetic Defect Screening Platform Segment by Type

Single Disease Gene Screening Platform

Whole Genome Multi-Disease Comprehensive Screening Platform

Pet Genetic Defect Screening Platform Segment by Application

Medical Institutions

Insurance Companies

Pet Breeding Companies

Others

Pet Genetic Defect Screening Platform Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pet Genetic Defect Screening Platform status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pet Genetic Defect Screening Platform key companies, revenue, market share, and recent developments.

3. To split the Pet Genetic Defect Screening Platform breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pet Genetic Defect Screening Platform market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pet Genetic Defect Screening Platform significant trends, drivers, influence factors in global and regions.

6. To analyze Pet Genetic Defect Screening Platform competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pet Genetic Defect Screening Platform market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pet Genetic Defect Screening Platform and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pet Genetic Defect Screening Platform.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pet Genetic Defect Screening Platform industry.

Chapter 3: Detailed analysis of Pet Genetic Defect Screening Platform company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pet Genetic Defect Screening Platform in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pet Genetic Defect Screening Platform in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pet Genetic Defect Screening Platform Industry Trends Table 2. Pet Genetic Defect Screening Platform Industry Drivers Table 3. Pet Genetic Defect Screening Platform Industry Opportunities and Challenges Table 4. Pet Genetic Defect Screening Platform Industry Restraints Table 5. Global Pet Genetic Defect Screening Platform Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pet Genetic Defect Screening Platform Revenue Share by Company (2021-2026) Table 7. Global Pet Genetic Defect Screening Platform Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pet Genetic Defect Screening Platform Key Company Manufacturing Base & Headquarters Table 9. Global Pet Genetic Defect Screening Platform Company, Product Type & Application Table 10. Global Pet Genetic Defect Screening Platform Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pet Genetic Defect Screening Platform by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Single Disease Gene Screening Platform Table 15. Significant Companies of Whole Genome Multi-Disease Comprehensive Screening Platform Table 16. Global Pet Genetic Defect Screening Platform Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Pet Genetic Defect Screening Platform Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Pet Genetic Defect Screening Platform Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Pet Genetic Defect Screening Platform Sales Value Share by Type (2021-2026) Table 20. Global Pet Genetic Defect Screening Platform Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Medical Institutions Table 22. Significant Companies of Insurance Companies Table 23. Significant Companies of Pet Breeding Companies Table 24. Significant Companies of Others Table 25. Global Pet Genetic Defect Screening Platform Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Pet Genetic Defect Screening Platform Sales Value by Application (2021-2026) & (US$ Million) Table 27. Global Pet Genetic Defect Screening Platform Sales Value by Application (2027-2032) & (US$ Million) Table 28. Global Pet Genetic Defect Screening Platform Sales Value Share by Application (2021-2026) Table 29. Global Pet Genetic Defect Screening Platform Sales Value Share by Application (2027-2032) Table 30. Global Pet Genetic Defect Screening Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global Pet Genetic Defect Screening Platform Sales Value by Region (2021-2026) & (US$ Million) Table 32. Global Pet Genetic Defect Screening Platform Sales Value Share by Region (2021-2026) Table 33. Global Pet Genetic Defect Screening Platform Sales Value by Region (2027-2032) & (US$ Million) Table 34. Global Pet Genetic Defect Screening Platform Sales Value Share by Region (2027-2032) Table 35. Global Pet Genetic Defect Screening Platform Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Pet Genetic Defect Screening Platform Sales Value by Country (2021-2026) & (US$ Million) Table 37. Global Pet Genetic Defect Screening Platform Sales Value Market Share by Country (2021-2026) Table 38. Global Pet Genetic Defect Screening Platform Sales Value by Country (2027-2032) & (US$ Million) Table 39. Global Pet Genetic Defect Screening Platform Sales Value Market Share by Country (2027-2032) Table 40. Wisdom Panel Company Information Table 41. Wisdom Panel Business Overview Table 42. Wisdom Panel Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 43. Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio Table 44. Wisdom Panel Recent Development Table 45. Embark Veterinary Company Information Table 46. Embark Veterinary Business Overview Table 47. Embark Veterinary Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 48. Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio Table 49. Embark Veterinary Recent Development Table 50. Basepaws Company Information Table 51. Basepaws Business Overview Table 52. Basepaws Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 53. Basepaws Pet Genetic Defect Screening Platform Product Portfolio Table 54. Basepaws Recent Development Table 55. Orivet Genetic Pet Care Company Information Table 56. Orivet Genetic Pet Care Business Overview Table 57. Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 58. Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio Table 59. Orivet Genetic Pet Care Recent Development Table 60. Paw Print Genetics Company Information Table 61. Paw Print Genetics Business Overview Table 62. Paw Print Genetics Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 63. Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio Table 64. Paw Print Genetics Recent Development Table 65. Animal Genetics Company Information Table 66. Animal Genetics Business Overview Table 67. Animal Genetics Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio Table 69. Animal Genetics Recent Development Table 70. VetGen Company Information Table 71. VetGen Business Overview Table 72. VetGen Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. VetGen Pet Genetic Defect Screening Platform Product Portfolio Table 74. VetGen Recent Development Table 75. Antagene Company Information Table 76. Antagene Business Overview Table 77. Antagene Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Antagene Pet Genetic Defect Screening Platform Product Portfolio Table 79. Antagene Recent Development Table 80. Laboklin Company Information Table 81. Laboklin Business Overview Table 82. Laboklin Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Laboklin Pet Genetic Defect Screening Platform Product Portfolio Table 84. Laboklin Recent Development Table 85. UC Davis Company Information Table 86. UC Davis Business Overview Table 87. UC Davis Pet Genetic Defect Screening Platform Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. UC Davis Pet Genetic Defect Screening Platform Product Portfolio Table 89. UC Davis Recent Development Table 90. OptiGen Company Information Table 91. OptiGen Business Overview Table 92. OptiGen Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 93. OptiGen Pet Genetic Defect Screening Platform Product Portfolio Table 94. OptiGen Recent Development Table 95. VHLGenetics Company Information Table 96. VHLGenetics Business Overview Table 97. VHLGenetics Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 98. VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio Table 99. VHLGenetics Recent Development Table 100. Sinogene Company Information Table 101. Sinogene Business Overview Table 102. Sinogene Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 103. Sinogene Pet Genetic Defect Screening Platform Product Portfolio Table 104. Sinogene Recent Development Table 105. PawKnows Company Information Table 106. PawKnows Business Overview Table 107. PawKnows Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 108. PawKnows Pet Genetic Defect Screening Platform Product Portfolio Table 109. PawKnows Recent Development Table 110. Circle Dog Company Information Table 111. Circle Dog Business Overview Table 112. Circle Dog Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 113. Circle Dog Pet Genetic Defect Screening Platform Product Portfolio Table 114. Circle Dog Recent Development Table 115. BGI Genomics Company Information Table 116. BGI Genomics Business Overview Table 117. BGI Genomics Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 118. BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio Table 119. BGI Genomics Recent Development Table 120. GENEWIZ Company Information Table 121. GENEWIZ Business Overview Table 122. GENEWIZ Pet Genetic Defect Screening Platform Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 123. GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio Table 124. GENEWIZ Recent Development Table 125. Research Programs/Design for This Report Table 126. Authors List of This Report Table 127. Secondary Sources Table 128. Primary Sources List of Figures Figure 1. Pet Genetic Defect Screening Platform Product Image Figure 2. Global Pet Genetic Defect Screening Platform Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pet Genetic Defect Screening Platform Market Size (2021-2032) & (US$ Million) Figure 4. Global Pet Genetic Defect Screening Platform Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Single Disease Gene Screening Platform Image Figure 8. Whole Genome Multi-Disease Comprehensive Screening Platform Image Figure 9. Global Pet Genetic Defect Screening Platform Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Pet Genetic Defect Screening Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Pet Genetic Defect Screening Platform Sales Value Share by Type (2021-2032) Figure 12. Medical Institutions Image Figure 13. Insurance Companies Image Figure 14. Pet Breeding Companies Image Figure 15. Others Image Figure 16. Global Pet Genetic Defect Screening Platform Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Pet Genetic Defect Screening Platform Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Pet Genetic Defect Screening Platform Sales Value Share by Application (2021-2032) Figure 19. Global Pet Genetic Defect Screening Platform Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Pet Genetic Defect Screening Platform Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 21. North America Pet Genetic Defect Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 22. North America Pet Genetic Defect Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Europe Pet Genetic Defect Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 24. Europe Pet Genetic Defect Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 25. Asia-Pacific Pet Genetic Defect Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 26. Asia-Pacific Pet Genetic Defect Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 27. South America Pet Genetic Defect Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 28. South America Pet Genetic Defect Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Middle East & Africa Pet Genetic Defect Screening Platform Sales Value (2021-2032) & (US$ Million) Figure 30. Middle East & Africa Pet Genetic Defect Screening Platform Sales Value Share by Country (%), 2025 VS 2032 Figure 31. USA Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 32. USA Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 33. USA Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 34. Canada Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. Canada Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. Canada Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Mexico Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Mexico Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Mexico Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Germany Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Germany Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Germany Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. France Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. France Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. France Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. U.K. Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. U.K. Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. U.K. Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Italy Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Italy Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Italy Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Spain Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Spain Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Spain Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Russia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Russia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Russia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Netherlands Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Netherlands Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Netherlands Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Nordic Countries Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Nordic Countries Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Nordic Countries Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. China Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. China Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. China Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Japan Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Japan Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Japan Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. South Korea Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. South Korea Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. South Korea Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. India Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. India Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. India Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Australia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Australia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Australia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Southeast Asia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Southeast Asia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Southeast Asia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Brazil Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Brazil Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Brazil Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Argentina Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Argentina Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Argentina Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Chile Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Chile Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Chile Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Colombia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Colombia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Colombia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Peru Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Peru Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Peru Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Saudi Arabia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Saudi Arabia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Israel Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Israel Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Israel Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. UAE Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. UAE Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. UAE Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Turkey Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Turkey Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Turkey Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Iran Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Iran Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Iran Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Egypt Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Egypt Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Egypt Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Years Considered Figure 116. Research Process Figure 117. Key Executives Interviewed

Scope & coverage.

Types
  • Single Disease Gene Screening Platform
  • Whole Genome Multi-Disease Comprehensive Screening Platform
Applications
  • Medical Institutions
  • Insurance Companies
  • Pet Breeding Companies
  • Others
Companies covered
  • Wisdom Panel
  • Embark Veterinary
  • Basepaws
  • Orivet Genetic Pet Care
  • Paw Print Genetics
  • Animal Genetics
  • VetGen
  • Antagene
  • Laboklin
  • UC Davis
  • OptiGen
  • VHLGenetics
  • Sinogene
  • PawKnows
  • Circle Dog
  • BGI Genomics
  • GENEWIZ

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pet Genetic Defect Screening Platform Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pet Genetic Defect Screening Platform Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pet Genetic Defect Screening Platform Market Dynamics
  1. 2.1 Pet Genetic Defect Screening Platform Industry Trends
  2. 2.2 Pet Genetic Defect Screening Platform Industry Drivers
  3. 2.3 Pet Genetic Defect Screening Platform Industry Opportunities and Challenges
  4. 2.4 Pet Genetic Defect Screening Platform Industry Restraints
3 Pet Genetic Defect Screening Platform Market by Company
  1. 3.1 Global Pet Genetic Defect Screening Platform Company Revenue Ranking in 2025
  2. 3.2 Global Pet Genetic Defect Screening Platform Revenue by Company (2021-2026)
  3. 3.3 Global Pet Genetic Defect Screening Platform Company Ranking (2024-2026)
  4. 3.4 Global Pet Genetic Defect Screening Platform Company Manufacturing Base and Headquarters
  5. 3.5 Global Pet Genetic Defect Screening Platform Company Product Type and Application
  6. 3.6 Global Pet Genetic Defect Screening Platform Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pet Genetic Defect Screening Platform Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pet Genetic Defect Screening Platform Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pet Genetic Defect Screening Platform Market by Type
  1. 4.1 Pet Genetic Defect Screening Platform Type Introduction
  2. 4.1.1 Single Disease Gene Screening Platform
  3. 4.1.2 Whole Genome Multi-Disease Comprehensive Screening Platform
  4. 4.2 Global Pet Genetic Defect Screening Platform Sales Value by Type
  5. 4.2.1 Global Pet Genetic Defect Screening Platform Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Pet Genetic Defect Screening Platform Sales Value by Type (2021-2032)
  7. 4.2.3 Global Pet Genetic Defect Screening Platform Sales Value Share by Type (2021-2032)
5 Pet Genetic Defect Screening Platform Market by Application
  1. 5.1 Pet Genetic Defect Screening Platform Application Introduction
  2. 5.1.1 Medical Institutions
  3. 5.1.2 Insurance Companies
  4. 5.1.3 Pet Breeding Companies
  5. 5.1.4 Others
  6. 5.2 Global Pet Genetic Defect Screening Platform Sales Value by Application
  7. 5.2.1 Global Pet Genetic Defect Screening Platform Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Pet Genetic Defect Screening Platform Sales Value by Application (2021-2032)
  9. 5.2.3 Global Pet Genetic Defect Screening Platform Sales Value Share by Application (2021-2032)
6 Pet Genetic Defect Screening Platform Regional Value Analysis
  1. 6.1 Global Pet Genetic Defect Screening Platform Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pet Genetic Defect Screening Platform Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pet Genetic Defect Screening Platform Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pet Genetic Defect Screening Platform Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pet Genetic Defect Screening Platform Sales Value (2021-2032)
  7. 6.3.2 North America Pet Genetic Defect Screening Platform Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pet Genetic Defect Screening Platform Sales Value (2021-2032)
  10. 6.4.2 Europe Pet Genetic Defect Screening Platform Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pet Genetic Defect Screening Platform Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pet Genetic Defect Screening Platform Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pet Genetic Defect Screening Platform Sales Value (2021-2032)
  16. 6.6.2 South America Pet Genetic Defect Screening Platform Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pet Genetic Defect Screening Platform Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pet Genetic Defect Screening Platform Sales Value Share by Country, 2025 VS 2032
7 Pet Genetic Defect Screening Platform Country-level Value Analysis
  1. 7.1 Global Pet Genetic Defect Screening Platform Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pet Genetic Defect Screening Platform Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pet Genetic Defect Screening Platform Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pet Genetic Defect Screening Platform Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pet Genetic Defect Screening Platform Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pet Genetic Defect Screening Platform Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pet Genetic Defect Screening Platform Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wisdom Panel
  2. 8.1.1 Wisdom Panel Company Information
  3. 8.1.2 Wisdom Panel Business Overview
  4. 8.1.3 Wisdom Panel Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Wisdom Panel Pet Genetic Defect Screening Platform Product Portfolio
  6. 8.1.5 Wisdom Panel Recent Developments
  7. 8.2 Embark Veterinary
  8. 8.2.1 Embark Veterinary Company Information
  9. 8.2.2 Embark Veterinary Business Overview
  10. 8.2.3 Embark Veterinary Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Embark Veterinary Pet Genetic Defect Screening Platform Product Portfolio
  12. 8.2.5 Embark Veterinary Recent Developments
  13. 8.3 Basepaws
  14. 8.3.1 Basepaws Company Information
  15. 8.3.2 Basepaws Business Overview
  16. 8.3.3 Basepaws Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Basepaws Pet Genetic Defect Screening Platform Product Portfolio
  18. 8.3.5 Basepaws Recent Developments
  19. 8.4 Orivet Genetic Pet Care
  20. 8.4.1 Orivet Genetic Pet Care Company Information
  21. 8.4.2 Orivet Genetic Pet Care Business Overview
  22. 8.4.3 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Orivet Genetic Pet Care Pet Genetic Defect Screening Platform Product Portfolio
  24. 8.4.5 Orivet Genetic Pet Care Recent Developments
  25. 8.5 Paw Print Genetics
  26. 8.5.1 Paw Print Genetics Company Information
  27. 8.5.2 Paw Print Genetics Business Overview
  28. 8.5.3 Paw Print Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Paw Print Genetics Pet Genetic Defect Screening Platform Product Portfolio
  30. 8.5.5 Paw Print Genetics Recent Developments
  31. 8.6 Animal Genetics
  32. 8.6.1 Animal Genetics Company Information
  33. 8.6.2 Animal Genetics Business Overview
  34. 8.6.3 Animal Genetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Animal Genetics Pet Genetic Defect Screening Platform Product Portfolio
  36. 8.6.5 Animal Genetics Recent Developments
  37. 8.7 VetGen
  38. 8.7.1 VetGen Company Information
  39. 8.7.2 VetGen Business Overview
  40. 8.7.3 VetGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  41. 8.7.4 VetGen Pet Genetic Defect Screening Platform Product Portfolio
  42. 8.7.5 VetGen Recent Developments
  43. 8.8 Antagene
  44. 8.8.1 Antagene Company Information
  45. 8.8.2 Antagene Business Overview
  46. 8.8.3 Antagene Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Antagene Pet Genetic Defect Screening Platform Product Portfolio
  48. 8.8.5 Antagene Recent Developments
  49. 8.9 Laboklin
  50. 8.9.1 Laboklin Company Information
  51. 8.9.2 Laboklin Business Overview
  52. 8.9.3 Laboklin Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Laboklin Pet Genetic Defect Screening Platform Product Portfolio
  54. 8.9.5 Laboklin Recent Developments
  55. 8.10 UC Davis
  56. 8.10.1 UC Davis Company Information
  57. 8.10.2 UC Davis Business Overview
  58. 8.10.3 UC Davis Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  59. 8.10.4 UC Davis Pet Genetic Defect Screening Platform Product Portfolio
  60. 8.10.5 UC Davis Recent Developments
  61. 8.11 OptiGen
  62. 8.11.1 OptiGen Company Information
  63. 8.11.2 OptiGen Business Overview
  64. 8.11.3 OptiGen Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  65. 8.11.4 OptiGen Pet Genetic Defect Screening Platform Product Portfolio
  66. 8.11.5 OptiGen Recent Developments
  67. 8.12 VHLGenetics
  68. 8.12.1 VHLGenetics Company Information
  69. 8.12.2 VHLGenetics Business Overview
  70. 8.12.3 VHLGenetics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  71. 8.12.4 VHLGenetics Pet Genetic Defect Screening Platform Product Portfolio
  72. 8.12.5 VHLGenetics Recent Developments
  73. 8.13 Sinogene
  74. 8.13.1 Sinogene Company Information
  75. 8.13.2 Sinogene Business Overview
  76. 8.13.3 Sinogene Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Sinogene Pet Genetic Defect Screening Platform Product Portfolio
  78. 8.13.5 Sinogene Recent Developments
  79. 8.14 PawKnows
  80. 8.14.1 PawKnows Company Information
  81. 8.14.2 PawKnows Business Overview
  82. 8.14.3 PawKnows Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  83. 8.14.4 PawKnows Pet Genetic Defect Screening Platform Product Portfolio
  84. 8.14.5 PawKnows Recent Developments
  85. 8.15 Circle Dog
  86. 8.15.1 Circle Dog Company Information
  87. 8.15.2 Circle Dog Business Overview
  88. 8.15.3 Circle Dog Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Circle Dog Pet Genetic Defect Screening Platform Product Portfolio
  90. 8.15.5 Circle Dog Recent Developments
  91. 8.16 BGI Genomics
  92. 8.16.1 BGI Genomics Company Information
  93. 8.16.2 BGI Genomics Business Overview
  94. 8.16.3 BGI Genomics Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  95. 8.16.4 BGI Genomics Pet Genetic Defect Screening Platform Product Portfolio
  96. 8.16.5 BGI Genomics Recent Developments
  97. 8.17 GENEWIZ
  98. 8.17.1 GENEWIZ Company Information
  99. 8.17.2 GENEWIZ Business Overview
  100. 8.17.3 GENEWIZ Pet Genetic Defect Screening Platform Revenue and Gross Margin (2021-2026)
  101. 8.17.4 GENEWIZ Pet Genetic Defect Screening Platform Product Portfolio
  102. 8.17.5 GENEWIZ Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst